| Abstrakt: |
To evaluate the frequency of oral lesions, olfactory and gustatory disorders, and xerostomia resulting from COVID-19. This observational study, which was approved by an Ethics Committee, was conducted with 414 patients. All patients were diagnosed by reverse transcription-polymerase chain reaction assay and considered to have mild symptoms, according to the latest World Health Organization joint report. For each patient, a clinical evaluation of the oral cavity and a questionnaire to assess functional alterations were performed. Of the 414 patients, 139 presented clinical manifestations, and the most prevalent were oral lesions (19.1%), followed by gustatory disorders (18.1%), xerostomia (14.2%), and olfactory dysfunction (14%). Among the oral lesions, there was a miscellaneous location and clinical presentation. The occurrence involving lips and tongue represented 49 oral lesions, the most prevalent being, respectively, ulcerations (n=51), candidiasis (n=8), and erythema or red plaques (n=7). Fifty patients died. Therefore, oral lesions, olfactory and gustatory dysfunctions, and xerostomia are common symptoms associated with COVID-19. However, it cannot be concluded that they are directly caused by SARS-CoV-2, since some drugs used in the treatment of COVID-19 may interact with the development of oral alterations and xerostomia. Acknowledgment: CNPq e FAPEMIG [ABSTRACT FROM AUTHOR] |
Full Text from ScienceDirect